74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
English (International)
ResMed Inc
Closed
SectorHealthcare
232.83 -3.13
Overview
Share price change
24h
Min
231.18
Max
239.3
Income | 44M 393M |
|---|---|
Sales | 87M 1.4B |
P/E Sector Avg | 24.993 61.417 |
Dividend yield | 0.89 |
Profit margin | 27.593 |
Employees | 10,600 |
EBITDA | 63M 566M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +23.34% upside |
Dividend yield Sector Avg | 0.89% 2.40% |
|---|---|
Next Earnings | 22 Apr 2026 |
Next Dividend date | 19 Mar 2026 |
Next Ex Dividend date | 7 May 2026 |
Market Cap | -371M 37B |
|---|---|
Previous open | 235.96 |
Previous close | 232.83 |
ResMed Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
ResMed Inc Forecast
Price Target
By TipRanks
23.34% upside
12 Months Forecast
Average 296.2 USD 23.34%
High 345 USD
Low 265 USD
Based on 12 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About ResMed Inc
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Live chat